TECHNESCAN SESTAMIBI

This brand name is authorized in Austria, Estonia, France, Lithuania, Romania.

Active ingredients

The drug TECHNESCAN SESTAMIBI contains one active pharmaceutical ingredient (API):

1
UNII N6OU7HJ70P - TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
 

Technetium 99mTc sestamibi is a coordination complex consisting of the radioisotope technetium-99m bound to six methoxyisobutylisonitrile (MIBI) ligands, hence the name sesta (6) MIBI. Following intravenous injection of the drug, Technetium 99mTc sestamibi is taken up by the myocardium, parathyroid, and/or breast tissue.

 
Read more about Technetium ⁹⁹ᵐTc sestamibi

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V09GA01 Technetium (99mTc) sestamibi V Various → V09 Diagnostic radiopharmaceuticals → V09G Cardiovascular system → V09GA Technetium (99mTc) compounds
Discover more medicines within V09GA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1282968
FR Base de données publique des médicaments 69667836
LT Valstybinė vaistų kontrolės tarnyba 1024536
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68394001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.